CD274 and neoplasm: Interestingly, recent experimentation has revealed that certain PDT PSs, when coupled with appropriate anti-tumor agents, can potentially overcome the challenges of PD-L1 up-regulation and tumor hypoxia in PDT, and so ultimately improve treatment outcomes [60].